News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • BMW cuts 2026 automotive margin and delivery guidance, sending shares down over 7%.
  • Barclays ends Europe underweight, raises Stoxx 600 target to 670 and upgrades the Luxury sector.
  • European stocks pause near STOXX 600 highs as investors await Fed guidance and Eurozone inflation data after a U.S.-Iran deal.
  • UK inflation held at 2.8% with services rising, keeping the Bank of England on edge and UK stocks slipping.
  • Straumann sharply raised its 2026 core-EBIT margin target, triggering a strong share rally.
  • PZ Cussons upgraded 2026 adjusted operating profit guidance and cited Naira stabilisation, lifting its shares.
  • Japan proposes a two-year cut to the food consumption tax to about 1%, raising fiscal pressure without funding details.

Latest Articles

IAEA Presses Iran to Disclose Status of Enriched Uranium After June Strikes

IAEA Presses Iran to Disclose Status of Enriched Uranium After June Strikes

The International Atomic Energy Agency has told member states that Iran must promptly provide information on its enriched uranium following military strikes on its nuclear sites in June 2025. A confidential IAEA report says the agency has not received required information, has been denied access to most facilities except Bushehr, and cannot verify …

Five Below Shares Drop Sharply as Guidance Assumptions Spur Investor Concern

Five Below Shares Drop Sharply as Guidance Assumptions Spur Investor Concern

Five Below reported stronger-than-expected fiscal Q1 2026 results, yet its stock plunged 12.1% in morning trading after an after-hours selloff extended into the regular session. The company topped consensus on both earnings and revenue, driven by substantial comparable-store sales and higher transaction volume. The market reaction centered on the c…

Pinterest Shares Jump After $4 Billion AWS Cloud Commitment Through 2031

Pinterest Shares Jump After $4 Billion AWS Cloud Commitment Through 2031

Pinterest shares rose sharply after the company disclosed a $4 billion agreement naming Amazon Web Services its Preferred Cloud Services Provider through 2031. The pact is intended to accelerate Pinterest’s AI roadmap, improve search and shopping responsiveness, and update the platform’s infrastructure that supports visual discovery for over 600 mi…

Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia

Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia

Nexalin Technology announced the issuance of U.S. Patent No. 12,629,519 for its transcranial alternating current dynamic frequency stimulation method targeting anxiety, depression, and insomnia. This patent strengthens the company's intellectual property portfolio, supporting its proprietary DIFS™ technology and virtual NeuroCare™ model for non-inv…

Micron Shares Plummet After Broadcom Shock Sends Semiconductor Stocks Lower

Micron Shares Plummet After Broadcom Shock Sends Semiconductor Stocks Lower

Micron Technology shares dropped sharply in morning trading after a broad selloff in the semiconductor sector was sparked by Broadcom’s post-earnings reaction. Despite strong revenue results at Broadcom, management’s decision not to lift its full-year AI semiconductor revenue target prompted a steep decline in that stock and a sector-wide de-riskin…

Why Alphabet’s $85B Share Sale Rewrites The Liquidity Playbook

Why Alphabet’s $85B Share Sale Rewrites The Liquidity Playbook

Alphabet's $85 billion stock sale is larger than most corporate liquidity events and will materially increase tradable supply, alter ETF/prime broker flows and shift buyback math. That creates a short-term dislocation and a mid-to-long-term opportunity to buy quality cash flow at a modest multiple if management deploys proceeds rationally. Trade pl…

Rumble Stock Pops After $270M GPU Cloud Deal as Cloud Pivot Gains Traction

Rumble Stock Pops After $270M GPU Cloud Deal as Cloud Pivot Gains Traction

Rumble's shares jumped sharply after the company announced a $270 million, multi-year contract for dedicated GPU cloud capacity. The agreement, signed June 3, 2026, involves NVIDIA Blackwell B300 systems and may increase in value or duration tied to market performance. The deal strengthens Rumble's push into cloud services and AI compute as the fir…

MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial

MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial

MAIA Biotechnology reports strong patient enrollment and dosing progress in its pivotal Phase 3 THIO-104 clinical trial evaluating ateganosine, a first-in-class telomere-targeting therapy for third-line treatment of advanced non-small cell lung cancer (NSCLC). The therapy shows a high potential based on favorable Phase 2 results and holds significa…

Publicis Upgrade: Buy the Dip — AI Angst Has Been Priced In

Publicis Upgrade: Buy the Dip — AI Angst Has Been Priced In

Publicis (PUBGY) looks like a classic opportunity to buy on fear: the business is cash-generative, pays a healthy yield, and is doubling down on AI through a strategic Microsoft relationship. Valuation is reasonable (P/E ~13.3, market cap ~$26.1B) and technical momentum is bullish. I upgrade to a buy and lay out an actionable trade with entry, stop…

Akari Therapeutics Releases CEO Corner Reflecting on Evolving ADC Landscape and Akari’s Differentiated PH1 Payload Platform Following ASCO 2026

Akari Therapeutics Releases CEO Corner Reflecting on Evolving ADC Landscape and Akari’s Differentiated PH1 Payload Platform Following ASCO 2026

Akari Therapeutics, an oncology biotech company focused on antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, discussed its differentiated PH1 payload platform and promising preclinical data for KRAS-driven cancers at ASCO 2026. The company outlined its strategy to address resistance issues faced by traditional ADCs and ann…

Decent Holding Reports Preliminary Unaudited RMB 55.1 Million Revenue and 387 New Community Locations Through May 2026; Advances an AI-Powered AgeTech Ecosystem

Decent Holding Reports Preliminary Unaudited RMB 55.1 Million Revenue and 387 New Community Locations Through May 2026; Advances an AI-Powered AgeTech Ecosystem

Decent Holding Inc. announced preliminary unaudited revenues of RMB 55.1 million (approximately US$8.0 million) and the addition of 387 new community service locations through May 2026, reflecting strong operational growth in their AI-powered elderly care ecosystem. The company integrates community networks with healthcare, wearables, AI, home robo…

Private credit funds face another redemption test in second quarter

Private credit funds face another redemption test in second quarter

Early filings and shareholder notices indicate private credit funds aimed at wealthy investors are again experiencing redemption pressure in the second quarter, driven by concerns over software exposure, valuations and limited transparency. Redemption windows at major U.S. non-traded private credit funds have recently closed, and managers reported …

Accenture: AI Is Accelerating The Consultancy, Not Replacing It

Accenture: AI Is Accelerating The Consultancy, Not Replacing It

Accenture is uniquely positioned to monetize enterprise AI deployment at scale. The stock trades cheaply on several cash-flow metrics while partnerships and federal work create visible revenue levers. This trade idea targets a recovery toward fair value over the next 180 trading days with a tight stop and clear catalysts.

Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value

Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value

Cosmos Health Inc. announced it has identified about $20 million in non-core assets, including real estate and digital assets, that can be monetized without impacting core healthcare operations. The proceeds could be used to pursue a meaningful acquisition or eliminate debt, aiming to unlock shareholder value and enhance financial stability.

Airbus Boosts May Deliveries to 81 as China Regulatory Hold Eases

Airbus Boosts May Deliveries to 81 as China Regulatory Hold Eases

Airbus increased its May aircraft deliveries to 81, a marked rise from 51 a year earlier, after a regulatory impasse with Chinese authorities that had delayed about 20 jets was resolved. The manufacturer declined to comment ahead of a scheduled monthly update. Analysts caution that broader supply-chain issues continue to pose a challenge to meeting…